Abstract
This review discusses the therapeutic potential of brain-derived neurotrophic factor (BDNF) for retinal degeneration. BDNF, nerve growth factor (NGF), neurotrophin 3 (NT-3) and NT-4/NT-5 belong to the neurotrophin family. These neuronal modulators activate a common receptor and a specific tropomyosin-related kinase (Trk) receptor. BDNF was identified as a photoreceptor protectant in models of retinal degeneration as early as 1992. However, development of effective therapeutics that exploit this pathway has been difficult due to challenges in sustaining therapeutic levels in the retina.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- BCL-2:
-
B-cell lymphoma 2
- BDNF:
-
Brain-derived neurotrophic factor
- HDACi:
-
Histone deacetylase inhibitor
- LE:
-
Light exposure
- MAPK:
-
Mitogen-activated protein kinase
- NGF:
-
Nerve growth factor
- ONL:
-
Outer nuclear layer
- PI3K:
-
Phosphoinositide 3-kinase
- Trk:
-
Tropomyosin-related kinase
References
Abe T, Saigo Y, Hojo M et al (2005) Protection of photoreceptor cells from Phototoxicity by transplanted retinal pigment epithelial cells expressing different neurotrophic factors. Cell Transplant 14:799–808
Abe T, Wakusawa R, Seto H et al (2008) Topical doxycycline can induce expression of BDNF in transduced retinal pigment epithelial cells transplanted into the subretinal space. Invest Ophthalmol Vis Sci 49:3631–3639
Abraham AG, O'Neill E (2014) PI3K/Akt-mediated regulation of p53 in cancer. Biochem Soc Trans 42:798–803
Almeida RD, Manadas BJ, Melo CV et al (2005) Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways. Cell Death Differ 12:1329–1343
Cerri E, Origlia N, Falsini B et al (2015) Conjunctivally applied BDNF protects photoreceptors from light-induced damage. Transl Vis Sci Technol 4:1
Chen H, Weber AJ (2001) BDNF enhances retinal ganglion cell survival in cats with optic nerve damage. Invest Ophthalmol Vis Sci 42:966–974
Chen H, Weber AJ (2004) Brain-derived neurotrophic factor reduces TrkB protein and mRNA in the normal retina and following optic nerve crush in adult rats. Brain Res 1011:99–106
Chong NH, Alexander RA, Waters L et al (1999) Repeated injections of a ciliary neurotrophic factor analogue leading to long-term photoreceptor survival in hereditary retinal degeneration. Invest Ophthalmol Vis Sci 40:1298–1305
Di Polo A, Cheng L, Bray GM et al (2000) Colocalization of TrkB and brain-derived neurotrophic factor proteins in green-red-sensitive cone outer segments. Invest Ophthalmol Vis Sci 41:4014–4021
Domenici L, Origlia N, Falsini B et al (2014) Rescue of retinal function by BDNF in a mouse model of glaucoma. PLoS One 9:e115579
Ferrari FK, Samulski T, Shenk T et al (1996) Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J Virol 70:3227–3234
Frank L, Wiegand SJ, Siuciak JA et al (1997) Effects of BDNF infusion on the regulation of TrkB protein and message in adult rat brain. Exp Neurol 145:62–70
Gauthier R, Joly S, Pernet V et al (2005) Brain-derived neurotrophic factor gene delivery to muller glia preserves structure and function of light-damaged photoreceptors. Invest Ophthalmol Vis Sci 46:3383–3392
Germana A, Sanchez-Ramos C, Guerrera MC et al (2010) Expression and cell localization of brain-derived neurotrophic factor and TrkB during zebrafish retinal development. J Anat 217:214–222
Ghazi-Nouri SM, Ellis JS, Moss S et al (2008) Expression and localisation of BDNF, NT4 and TrkB in proliferative vitreoretinopathy. Exp Eye Res 86:819–827
Guy J, Qi X, Muzyczka N et al (1999) Reporter expression persists 1 year after adeno-associated virus-mediated gene transfer to the optic nerve. Arch Ophthalmol 117:929–937
Harada T, Harada C, Kohsaka S et al (2002) Microglia-Muller glia cell interactions control neurotrophic factor production during light-induced retinal degeneration. J Neurosci 22:9228–9236
Hojo M, Abe T, Sugano E et al (2004) Photoreceptor protection by iris pigment epithelial transplantation transduced with AAV-mediated brain-derived neurotrophic factor gene. Invest Ophthalmol Vis Sci 45:3721–3726
Iraha S, Hirami Y, Ota S et al (2016) Efficacy of valproic acid for retinitis pigmentosa patients: a pilot study. Clin Ophthalmol 10:1375–1384
Johnson TV, Bull ND, Martin KR (2011) Neurotrophic factor delivery as a protective treatment for glaucoma. Exp Eye Res 93:196–203
Kaplan DR, Miller FD (2000) Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 10:381–391
Kimura A, Namekata K, Guo X et al (2014) Valproic acid prevents NMDA-induced retinal ganglion cell death via stimulation of neuronal TrkB receptor signaling. Am J Pathol 185(3):756–764
Klocker N, Cellerino A, Bahr M (1998) Free radical scavenging and inhibition of nitric oxide synthase potentiates the neurotrophic effects of brain-derived neurotrophic factor on axotomized retinal ganglion cells in vivo. J Neurosci 18:1038–1046
Koshimizu H, Kiyosue K, Hara T et al (2009) Multiple functions of precursor BDNF to CNS neurons: negative regulation of neurite growth, spine formation and cell survival. Mol Brain 2:27–27
LaVail MM, Unoki K, Yasumura D et al (1992) Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light. Proc Natl Acad Sci U S A 89:11249–11253
LaVail MM, Yasumura D, Matthes MT et al (1998) Protection of mouse photoreceptors by survival factors in retinal degenerations. Invest Ophthalmol Vis Sci 39:592–602
Lawrence JM, Keegan DJ, Muir EM et al (2004) Transplantation of Schwann cell line clones secreting GDNF or BDNF into the retinas of dystrophic Royal College of surgeons rats. Invest Ophthalmol Vis Sci 45:267–274
Lee R, Kermani P, Teng KK et al (2001) Regulation of cell survival by secreted Proneurotrophins. Science 294:1945–1948
Liu C, Chan CB, Ye K (2016) 7,8-dihydroxyflavone, a small molecular TrkB agonist, is useful for treating various BDNF-implicated human disorders. Transl Neurodegener 5:2
Lu B (2003) BDNF and activity-dependent synaptic modulation. Learn Mem (Cold Spring Harbor, NY) 10:86–98
Mansour-Robaey S, Clarke DB, Wang Y et al (1994) Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc Natl Acad Sci U S A 91(5):1632–1636
Marticorena J, Romano V, Gomez-Ulla F (2012) Sterile endophthalmitis after intravitreal injections. Mediat Inflamm 2012:928123
Nakazawa T, Tamai M, Mori N (2002) Brain-derived neurotrophic factor prevents axotomized retinal ganglion cell death through MAPK and PI3K signaling pathways. Invest Ophthalmol Vis Sci 43:3319–3326
Nguyen N, Lee SB, Lee YS et al (2009) Neuroprotection by NGF and BDNF against neurotoxin-exerted apoptotic death in neural stem cells are mediated through Trk receptors, activating PI3-kinase and MAPK pathways. Neurochem Res 34:942–951
Numakawa T, Suzuki S, Kumamaru E et al (2010) BDNF function and intracellular signaling in neurons. Histol Histopathol 25:237–258
Ochs G, Penn RD, York M et al (2000) A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:201–206
Okoye G, Zimmer J, Sung J et al (2003) Increased expression of brain-derived neurotrophic factor preserves retinal function and slows cell death from rhodopsin mutation or oxidative damage. J Neurosci 23:4164–4172
Ortín-Martínez A, Valiente-Soriano FJ, García-Ayuso D et al (2014) A novel in vivo model of focal light emitting diode-induced cone-photoreceptor Phototoxicity: neuroprotection afforded by Brimonidine, BDNF, PEDF or bFGF. PLoS One 9:e113798
Ren R, Li Y, Liu Z et al (2012) Long-term rescue of rat retinal ganglion cells and visual function by AAV-mediated BDNF expression after acute elevation of intraocular pressure. Invest Ophthalmol Vis Sci 53:1003–1011
Sakane T, Pardridge WM (1997) Carboxyl-directed pegylation of brain-derived neurotrophic factor markedly reduces systemic clearance with minimal loss of biologic activity. Pharm Res 14:1085–1091
Scharfman HE, Goodman JH, Sollas AL et al (2002) Spontaneous limbic seizures after intrahippocampal infusion of brain-derived neurotrophic factor. Exp Neurol 174:201–214
Seiler MJ, Thomas BB, Chen Z et al (2008) BDNF-treated retinal progenitor sheets transplanted to degenerate rats: improved restoration of visual function. Exp Eye Res 86:92–104
Vecino E, Garcı́a-Grespo D, Garcı́a M et al (2002) Rat retinal ganglion cells co-express brain derived neurotrophic factor (BDNF) and its receptor TrkB. Vis Res 42:151–157
Wilson RB, Kunchithapautham K, Br R (2007) Paradoxical role of BDNF: BDNF+/− retinas are protected against light damage–mediated stress. Invest Ophthalmol Vis Sci 48:2877–2886
Wu X, Chen PS, Dallas S et al (2008) Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons. Int J Neuropsychopharmacol 11:1123–1134
Wu CH, Hung TH, Chen CC et al (2014) Post-injury treatment with 7,8-dihydroxyflavone, a TrkB receptor agonist, protects against experimental traumatic brain injury via PI3K/Akt signaling. PLoS One 9:e113397
Yasuda S, Liang MH, Marinova Z et al (2009) The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol Psychiatry 14:51–59
Zhang Y, Wang W (2010) Effects of bone marrow mesenchymal stem cell transplantation on light-damaged retina. Invest Ophthalmol Vis Sci 51:3742–3748
Zhang M, Mo X, Fang Y et al (2009) Rescue of photoreceptors by BDNF gene transfer using in vivo electroporation in the RCS rat of retinitis pigmentosa. Curr Eye Res 34:791–799
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this paper
Cite this paper
Daly, C., Ward, R., Reynolds, A.L., Galvin, O., Collery, R.F., Kennedy, B.N. (2018). Brain-Derived Neurotrophic Factor as a Treatment Option for Retinal Degeneration. In: Ash, J., Anderson, R., LaVail, M., Bowes Rickman, C., Hollyfield, J., Grimm, C. (eds) Retinal Degenerative Diseases. Advances in Experimental Medicine and Biology, vol 1074. Springer, Cham. https://doi.org/10.1007/978-3-319-75402-4_57
Download citation
DOI: https://doi.org/10.1007/978-3-319-75402-4_57
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-75401-7
Online ISBN: 978-3-319-75402-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)